» Articles » PMID: 34452257

Micellar Antibiotics of

Abstract

Members of the genus, particularly the " group", are known to produce amphipathic lipopeptides with biosurfactant activity. This includes the surfactins, fengycins and iturins that have been associated with antibacterial, antifungal, and anti-viral properties. We have screened a large collection of , isolated from human, animal, estuarine water and soil samples and found that the most potent lipopeptide producers are members of the species . lipopeptides exhibited anti-bacterial activity which was localised on the surface of both vegetative cells and spores. Interestingly, lipopeptide micelles (6-10 nm diameter) were detectable in strains exhibiting the highest levels of activity. Micelles were stable (heat and gastric stable) and shown to entrap other antimicrobials produced by the host bacterium (exampled here was the dipeptide antibiotic chlorotetaine). Commercially acquired lipopeptides did not exhibit similar levels of inhibitory activity and we suspect that micelle formation may relate to the particular isomeric forms produced by individual bacteria. Using naturally produced micelle formulations we demonstrated that they could entrap antimicrobial compounds (e.g., clindamycin, vancomycin and resveratrol). Micellar incorporation of antibiotics increased activity. is a prolific producer of antimicrobials, and this phenomenon could be exploited naturally to augment antimicrobial activity. From an applied perspective, the ability to readily produce micelles and formulate with drugs enables a possible strategy for enhanced drug delivery.

Citing Articles

Genomic Insights into the Bactericidal and Fungicidal Potential of b12.3 Isolated in the Soil of Olkhon Island in Lake Baikal, Russia.

Romanenko M, Shikov A, Savina I, Shmatov F, Nizhnikov A, Antonets K Microorganisms. 2025; 12(12.

PMID: 39770653 PMC: 11676374. DOI: 10.3390/microorganisms12122450.


A Family of Cyclic Lipopeptides Found in Human Isolates of Bacillus Ameliorates Acute Colitis via Direct Agonism of Toll-Like Receptor 2 in a Murine Model of Inflammatory Bowel Disease.

Horwell E, Vittoria M, Hong H, Bearn P, Cutting S Dig Dis Sci. 2024; 69(10):3729-3741.

PMID: 39110366 PMC: 11489211. DOI: 10.1007/s10620-024-08534-2.


Antibiofilm Activity of the Marine Probiotic Bacillus subtilis C3 Against the Aquaculture-Relevant Pathogen Vibrio harveyi.

Petit C, Caudal F, Taupin L, Dufour A, Le Ker C, Giudicelli F Probiotics Antimicrob Proteins. 2024; .

PMID: 38329698 DOI: 10.1007/s12602-024-10229-z.


Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition.

Larsen I, Chenaux M, Collins F, Mandic A, Hansen L, Lauridsen C Sci Rep. 2023; 13(1):14941.

PMID: 37696924 PMC: 10495459. DOI: 10.1038/s41598-023-42128-8.


Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications.

Ceresa C, Fracchia L, Sansotera A, De Rienzo M, Banat I Pharmaceutics. 2023; 15(8).

PMID: 37631370 PMC: 10457971. DOI: 10.3390/pharmaceutics15082156.


References
1.
Croy S, Kwon G . Polymeric micelles for drug delivery. Curr Pharm Des. 2006; 12(36):4669-84. DOI: 10.2174/138161206779026245. View

2.
Johnson J, Yalkowsky S . Reformulation of a new vancomycin analog: An example of the importance of buffer species and strength. AAPS PharmSciTech. 2017; 7(1):E33-E37. DOI: 10.1208/pt070105. View

3.
Ongena M, Jacques P . Bacillus lipopeptides: versatile weapons for plant disease biocontrol. Trends Microbiol. 2008; 16(3):115-25. DOI: 10.1016/j.tim.2007.12.009. View

4.
Sumi C, Yang B, Yeo I, Hahm Y . Antimicrobial peptides of the genus Bacillus: a new era for antibiotics. Can J Microbiol. 2015; 61(2):93-103. DOI: 10.1139/cjm-2014-0613. View

5.
Wishart D, Djoumbou Feunang Y, Marcu A, Guo A, Liang K, Vazquez-Fresno R . HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2017; 46(D1):D608-D617. PMC: 5753273. DOI: 10.1093/nar/gkx1089. View